Melody Brown
Impact in
- Oncology top 10%
- Colorectal Cancer Treatments and Studies
- Cancer Treatment and Pharmacology
- Cancer-related Molecular Pathways
-
- Folate and B Vitamins Research
Papers in
-
- Quinazolinone synthesis and applications 4
- Co-authors
- Rosemary KimbellA.L. JackmanWilliam GibsonA H CalvertAnn L. JackmanG. Wynne AherneLloyd R. KèllandAnthea Hardcastle
- Journals
- Advances in experimental medicine and biology (3 papers)British Journal of Cancer (1 paper)Journal of Medicinal Chemistry (1 paper)PubMed (3 papers)
- Partner nations
- United KingdomFrance
In The Last Decade
Melody Brown
8 papers receiving 519 citations
Peers
Comparison fields: 5 of 61
- Oncology 292
- Rheumatology 82
- Molecular Biology 315
- Organic Chemistry 93
- Infectious Diseases 60
Countries citing papers authored by Melody Brown
This map shows the geographic impact of Melody Brown's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Melody Brown with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Melody Brown more than expected).
Fields of papers citing papers by Melody Brown
This network shows the impact of papers produced by Melody Brown. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Melody Brown. The network helps show where Melody Brown may publish in the future.
Co-authors
The 22 scholars most cited alongside Melody Brown, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1999 | 39 | |
| 2 | 1995 | 21 | |
| 3 | 1995 | 88 | |
| 4 | Quinazoline-based thymidylate synthase inhibitors: relationship between structural modifications and polyglutamation. | 1995 | 7 |
| 5 | 1993 | 6 | |
| 6 | 1993 | 38 | |
| 7 | ICI D1694, a quinazoline antifolate thymidylate synthase inhibitor that is a potent inhibitor of L1210 tumor cell growth in vitro and in vivo: a new agent for clinical study. | 1991 | 322 |
| 8 | A system for determining the pharmacology of indirect radiation sensitizer drugs on multicellular spheroids. | 1981 | 18 |
About Melody Brown
Melody Brown is a scholar working on Pharmaceutical Science, Organic Chemistry, Biotechnology, Oncology and Molecular Biology, having authored 8 papers that have together received 539 indexed citations. Recurring topics across this work include Biochemical and Molecular Research (5 papers), Quinazolinone synthesis and applications (4 papers), Colorectal Cancer Treatments and Studies (3 papers), Cancer therapeutics and mechanisms (2 papers), RNA Interference and Gene Delivery (1 paper), biodegradable polymer synthesis and properties (1 paper), Cancer Research and Treatments (1 paper) and Biopolymer Synthesis and Applications (1 paper). The work is most often cited by research in Oncology (292 citations), Rheumatology (82 citations), Molecular Biology (315 citations), Organic Chemistry (93 citations) and Infectious Diseases (60 citations). Melody Brown has collaborated with scholars based in United Kingdom and France. Frequent co-authors include Rosemary Kimbell, A.L. Jackman, William Gibson, A H Calvert, Ann L. Jackman, G. Wynne Aherne, Lloyd R. Kèlland, William Gibson, Anthea Hardcastle and J. Michael Wardleworth. Their work appears in journals such as Advances in experimental medicine and biology, British Journal of Cancer, Journal of Medicinal Chemistry and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.